In spite of several decades of research, no effective treatment to skin injuries following exposure to sulfur mustard (HD) has yet been found. In the present study, the mouse ear vesicant model was applied to awake mice in order to evaluate the efficiency of potential anti-inflammatory treatments in preventing HD-induced skin damages. Clinical follow-up and histological evaluation were used to characterize the injuries to the skin and to evaluate the efficiency of the drugs that were applied. Thus, the extent of mouse ear oedema and the histopathological changes following a single application of 0.2 or 1 L of neat HD for 10 min (representing moderate and severe lesions, respectively), were monitored. Typical HD skin lesions were observed including epithelial and dermal damage. The development of the injury in mouse ears was found to be very similar to that reported in human skin. Screening of post-exposure topical steroids and non-steroidal anti inflammatory drugs (NSAIDs) proved that HD-induced inflammation could be diminished significantly as long as the treatment was applied during the early stages following exposure. A combined application of these drugs approved to be particularly effective in reducing inflammation.
Smith KJ , Hurst CG , Moeller RB , Skelton HG , Sidell FR . Sulfur mustard: its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its longterm health effects, and new developments for protection and therapy . J Am Acad Dermatol1995; 32: 765–775 .
2.
Papirmeister B , Feister AJ , Robinson SI , Ford RD . The sulfur mustard injury: description of lesions and resulting incapacitation. Medical defense against mustard gas, toxic mechanisms and pharmacological implications. Boca Raton, FL: CRC Press , 1991: 13–42.
3.
Papirmeister B , Feister AJ , Robinson SI , Ford RD . Histand cytopathology of acute epithelial lesions. Medical defense against mustard gas, toxic mechanisms and pharmacological implications. Boca Raton, FL: CRC Press , 1991: 43–61
4.
Petrali JP , Oglesby-Megee S.Toxicity of mustard gas skin lesion . Microsc Res Tech1997; 37: 221–228 .
5.
Cowan FM , Broomfield CA . Putative roles of inflammation in the dermatopathology of sulfur mustard . Cell Biol Toxicol1993; 9: 201–213 .
6.
Monteiro-Riviere NA , Inman AO . Ultrastructural characterization of sulfur mustard-induced vesication in isolated perfused porcine skin . Microsc Res Tech1997; 37: 229–241 .
7.
Papirmeister B , Gross CL , Petrali JB , Hixson CJ . Pathology produced by sulfur mustard in human skin graft on athymic nude mice: I. Gross and light micro scopic changes . J Toxicol Cutaneous Ocul Toxicol1984; 3: 371–391 .
8.
Papirmeister B , Gross CL , Petrali JB , Hixson CJ . Pathology produced by sulfur mustard in human skin graft on athymic nude mice: II. Ultrastructural changes . J Toxicol Cutaneous Ocul Toxicol1984; 3: 393–408 .
9.
Braue EH , Koplovitz I , Mitcheltree LW , Clayson ET , Litchfield MR , Bangledorf CR . Characterization of the sulfur mustard vapor induced cutaneous lesions on hairless guinea pigs . Toxicol Methods1992; 2: 242–254 .
10.
Braue EH , Nalls CR , Way RA , Zallnick JE , Rieder RG , Mitcheltree LW . The haired guinea pig as a vesicant animal model . In Proceedings of the 1996 Medical Defense Bioscience Review. US Army Medical Research and Materiel Command, MD, USA, 1996: 685–693 .
11.
Chauhan RS , Murthy LVR , Arora U , Malhotra PR . Structural changes induced by sulphur mustard in rabbit skin . J Appl Toxicol1996; 16: 491–495 .
12.
Riviere JE , Brooks JD , Williams PL , Monteiro-Riviere NA . Toxicokinetics of topical sulfur mustard penetration, disposition, and vascular toxicity in isolated perfused porcine skin . Toxicol Appl Pharmacol1995; 135: 25–34 .
13.
Smith KJ , Skelton HG , Hobson DW , Reid FM , Blank JA , Hurst CG . Cutaneous histopathologic features in weanling pigs after exposure to three different doses of liquid sulfur mustard . Am J Dermatopathol1996; 18: 515–520 .
14.
Zlotogorski A , Goldenhersh M , Shafran A.A model for quantitative measurement of sulfur mustard skin lesions in the rabbit ear . Toxicology1997; 120: 105–110 .
15.
Casillas RP , Mitcheltree LW , Stemler FW . The mouse ear model of cutaneous sulfur mustard injury . Toxicol Methods1997; 7: 381–397 .
16.
Crummey A , Harper GP , Boyle EA , Mangan FR . Inhibition of arachidonic acid-induced ear oedema as a model for assessing topical anti-inflammatory compounds . Agents Actions1987; 20: 69–76 .
17.
Patrick E , Burkhalter A , Maibach H.Mouse ear assays as models for studying mechanisms of chemically induced irritation . Models Dermatol1987; 3: 86–92 .
18.
Papirmeister B , Gross CL , Meier HL , Petrali JP , Johnson JB . Molecular basis for mustard-induced vesication . Fundam Appl Toxicol1985; 5: S134–S149 .
19.
Somani SM , Babu SR . Toxicodynamics of sulfur mustard . Int J Clin Pharmcol Ther Toxicol1989; 27: 419–435 .
20.
Zhang Z , Peters BP , Monteiro-Riviere NA . Assessment of sulfur mustard interaction with basement membrane components . Cell Biol Toxicol1995; 11: 89–101 .
21.
Arroyo CM . A novel multiple therapeutic approach (MTA) for suppression of the inflammatory and immunology responses observed in vesicant injury . In Proceedings of the 1998 Medical Defense Bioscience Review. US Army Medical Research and Materiel Command, MD, USA, 1998: 1–13 .
22.
Kadar T , Fishbeine E , Meshulam Y , et al. Treatment of skin injuries induced by sulfur mustard with calm odulin antagonists, using the pig model . J Appl Toxicol2000; 20: S133–S136 .
23.
Willems JL . Clinical management of mustard gas casualties . Annal Med Militaris1989; 3(suppl): 1–61 .
24.
Wormser U.Toxicology of mustard gas . TIPS1991; 12: 64–167 .
25.
Papirmeister B.Excitement in vesicant research <Eth> yesterday, today and tomorrows In Proceedings of the 1993 Medical Defense Bioscience Review. US Army Medical Research and Materiel Command, MD, USA, 1993: 1–14 .
26.
Aasted A , Darre E , Wulf HC . Mustard gas: clinical, toxicological, and mutagenic aspects based on modern experience . Ann Plast Surg1987; 19: 330–333 .
27.
Casillas RP , Kiser RC , Truxall JA , et al. Therapeutic approaches to dermatotoxicity by sulfur mustard: I. Modulation of sulfur mustard-induced cutaneous injury in the mouse ear vesicant model . J Appl Toxicol, 2000; 20(suppl 1): S145–S151 .
28.
Babin MC , Ricketts K , Skvorak JP , Gazaway M , Mitcheltree LW , Casillas RP . Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM) . J Appl Toxicol, 2000; 20(suppl 1): S141–S144 .
29.
Zhang Z , Riviere JE , Monteiro-Riviere NA . Evaluation of protective effects of sodium thiosulfate, cysteine, niacinamide and indomethacin on sulfur mustardtreated isolated perfused porcine skin . Chem Biol Interact1995; 14: 249–262 .
30.
Wormser U , Brodsky B , Nyska A , Sintov A . Iodine protects against sulfur mustard-induced skin lesions . In Proceedings of the 2000 Medical Defense Bioscience Review. US Army Medical Research and Materiel Command, MD, USA, 2000: 522–529 .
31.
Casillas RP , Smith KJ , Castrejon LR , Tezak-Reid T , Lee RB , Stemler FW . Effect of topically applied drugs against HD-induced cutaneous injury in the mouse ear edema model . In Proceedings of the 1996 Medical Defense Bioscience Review. US Army Medical Research and Materiel Command, MD, USA, 1996: 801–809 .
32.
Monteiro-Riviere NA , Inman AO , Babin MC , Casillas RP . Assessment of epidermal–dermal junction epitopes in the HD-exposed mouse ear vesicant model . In Proceedings of the 1998 Medical Defense Bioscience Review. US Army Medical Research and Materiel Command, MD, USA, 1998: 1–13 .
